Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Business

Tissue maker Essity’s profit tumbles as input and distribution costs bite

2022 01 26T060839Z 1 LYNXMPEI0P06D RTROPTP 4 ESSITY RESULTS - Global Banking | Finance

STOCKHOLM (Reuters) -Hygiene products group Essity on Wednesday reported a bigger-than-expected drop in fourth-quarter profit and said it planned to raise prices further in the face of record high costs for raw material, energy and distribution.

Operating profit at the world’s second-biggest maker of consumer tissue fell 34% from a year earlier to 2.75 billion Swedish crowns ($297 million) despite an 11% rise in sales. Five analysts polled by Refinitiv had on average forecast a 3.33 billion crown profit.

Essity, which is also the global leader in hygiene products for businesses and in incontinence products, announced plans to raise prices in all product categories and markets this year to compensate for the substantially higher costs.

“We do not expect a decrease in the historically high costs for raw material, energy and distribution in the near term,” Chief Executive Officer Magnus Groth said in a statement.

“Price increases are therefore essential to compensate for the higher costs while we continue to increase customer and consumer value through leading innovations and implement efficiency measures to achieve cost savings.”

The timing and size of the planned price increases would be managed locally, Essity added.

Essity, a rival to Procter & Gamble and Kimberly-Clark, proposed a dividend of 7 crowns per share for 2021, up 4% from the year before.

($1 = 9.2543 Swedish crowns)

(Reporting by Anna Ringstrom; Editing by Subhranshu Sahu)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post